HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI

被引:20
作者
Auer, Timo Alexander [1 ,6 ]
Walter-Rittel, Thula [1 ]
Geisel, Dominik [1 ]
Schoening, Wenzel [2 ]
Schmelzle, Moritz [2 ]
Mueller, Tobias [3 ]
Sinn, Bruno [4 ]
Denecke, Timm [5 ]
Hamm, Bernd [1 ]
Fehrenbach, Uli [1 ]
机构
[1] Charite Univ Med Berlin, Campus Virchow Klinikum, Radiol Klin, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Charite Univ Med Berlin, Campus Charite Mitte Campus Virchow Klinikum, Dept Surg, Augustenburger Pl 1, D-13353 Berlin, Germany
[3] Charite Univ Med Berlin, Campus Virchow Klinikum, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany
[4] Charite Univ Med Berlin, Inst Pathol, Charite Pl 1, D-10117 Berlin, Germany
[5] Univ Klinikum Leipzig, Dept Diagnost & Intervent Radiol, Liebigstr 20, D-04103 Leipzig, Germany
[6] Berlin Inst Hlth BIH, Anna Louisa Karsch Str 2, D-10178 Berlin, Germany
关键词
Liver; Magnetic resonance imaging; Focal nodular hyperplasia; Hepatocellular adenoma; Gd-EOB;
D O I
10.1186/s12880-021-00552-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundRecent studies provide evidence that hepatocellular adenomas (HCAs) frequently take up gadoxetic acid (Gd-EOB) during the hepatobiliary phase (HBP). The purpose of our study was to investigate how to differentiate between Gd-EOB-enhancing HCAs and focal nodular hyperplasias (FNHs). We therefore retrospectively included 40 HCAs classified as HBP Gd-EOB-enhancing lesions from a sample of 100 histopathologically proven HCAs in 65 patients. These enhancing HCAs were matched retrospectively with 28 FNH lesions (standard of reference: surgical resection). Two readers (experienced abdominal radiologists blinded to clinical data) reviewed the images evaluating morphologic features and subjectively scoring Gd-EOB uptake (25-50%, 50-75% and 75-100%) for each lesion. Quantitative lesion-to-liver enhancement was measured in arterial, portal venous (PV), transitional and HBP. Additionally, multivariate regression analyses were performed.ResultsSubjective scoring of intralesional Gd-EOB uptake showed the highest discriminatory accuracies (AUC: 0.848 (R#1); 0.920 (R#2)-p<0.001) with significantly higher uptake scores assigned to FNHs (Cut-off: 75%-100%). Typical lobulation and presence of a central scar in FNH achieved an accuracy of 0.750 or higher in at least one reader (lobulation-AUC: 0.809 (R#1); 0.736 (R#2); central scar-AUC: 0.595 (R#1); 0.784 (R#2)). The multivariate regression emphasized the discriminatory power of the Gd-EOB scoring (p=0.001/OR:22.15 (R#1) and p<0.001/OR:99.12 (R#2). The lesion-to-liver ratio differed significantly between FNH and HCA in the PV phase and HBP (PV: 132.9 (FNH) and 110.2 (HCA), p=0.048 and HBP: 110.3 (FNH) and 39.2 (HCA), p<0.001)), while the difference was not significant in arterial and transitional contrast phases (p>0.05).ConclusionEven in HBP-enhancing HCA, characterization of Gd-EOB uptake was found to provide the strongest discriminatory power in differentiating HCA from FNH. Furthermore, a lobulated appearance and a central scar are more frequently seen in FNH than in HCA.
引用
收藏
页数:11
相关论文
共 32 条
[1]   Inflammatory Hepatocellular Adenomas Can Mimic Focal Nodular Hyperplasia on Gadoxetic Acid-Enhanced MRI [J].
Agarwal, Sheela ;
Fuentes-Orrego, Jorge M. ;
Arnason, Thomas ;
Misdraji, Joseph ;
Jhaveri, Kartik S. ;
Harisinghani, Mukesh ;
Hahn, Peter F. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (04) :W408-W414
[2]   Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? [J].
Auer, Timo Alexander ;
Fehrenbach, Uli ;
Grieser, Christian ;
Penzkofer, Tobias ;
Geisel, Dominik ;
Schmelzle, Moritz ;
Mueller, Tobias ;
Blaeker, Hendrik ;
Seehofer, Daniel ;
Denecke, Timm .
EUROPEAN RADIOLOGY, 2020, 30 (06) :3497-3506
[3]  
Barthelmes Ludger, 2005, HPB (Oxford), V7, P186, DOI 10.1080/13651820510028954
[4]   Risk factors for bleeding in hepatocellular adenoma [J].
Bieze, M. ;
Phoa, S. S. K. S. ;
Verheij, J. ;
van Lienden, K. P. ;
van Gulik, T. M. .
BRITISH JOURNAL OF SURGERY, 2014, 101 (07) :847-855
[5]   Hepatocellular adenoma: what is new in 2008 [J].
Bioulac-Sage, Paulette ;
Laumonier, Herve ;
Laurent, Christophe ;
Zucman-Rossi, Jessica ;
Balabaud, Charles .
HEPATOLOGY INTERNATIONAL, 2008, 2 (03) :316-321
[6]   Genotype phenotype classification of hepatocellular adenoma [J].
Bioulac-Sage, Paulette ;
Blanc, Lean Frederic ;
Rebouissou, Sandra ;
Balabaud, Charles ;
Zucman-Rossi, Jessica .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (19) :2649-2654
[7]   Hepatocellular Adenoma Management and Phenotypic Classification: the Bordeaux Experience [J].
Bioulac-Sage, Paulette ;
Laumonier, Herve ;
Couchy, Gabrielle ;
Le Bail, Brigitte ;
Cunha, Antonio Sa ;
Rullier, Anne ;
Laurent, Christophe ;
Blanc, Jean-Frederic ;
Cubel, Gaelle ;
Trillaud, Herve ;
Zucman-Rossi, Jessica ;
Balabaud, Charles ;
Saric, Jean .
HEPATOLOGY, 2009, 50 (02) :481-489
[8]   EASL Clinical Practice Guidelines on the management of benign liver tumours [J].
Colombo, Massimo ;
Forner, Alejandro ;
Ijzermans, Jan ;
Paradis, Valerie ;
Reeves, Helen ;
Vilgrain, Valerie ;
Zucman-Rossi, Jessica .
JOURNAL OF HEPATOLOGY, 2016, 65 (02) :386-398
[9]   Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI [J].
Denecke, Timm ;
Steffen, Ingo G. ;
Agarwal, Sheela ;
Seehofer, Daniel ;
Kroencke, Thomas ;
Haenninen, Enrique Lopez ;
Kramme, Incken-Birthe ;
Neuhaus, Peter ;
Saini, Sanjay ;
Hamm, Bernd ;
Grieser, Christian .
EUROPEAN RADIOLOGY, 2012, 22 (08) :1769-1775
[10]   A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas [J].
Dokmak, Safi ;
Paradis, Valerie ;
Vilgrain, Valerie ;
Sauvanet, Alain ;
Farges, Olivier ;
Valla, Dominique ;
Bedossa, Pierre ;
Belghiti, Jacques .
GASTROENTEROLOGY, 2009, 137 (05) :1698-1705